Q2057 Afamitresgene autoleucel, including leukapheresis and dose preparation procedures, per therapeutic dose

Short descriptor: Afamitresgene autoleucel

✓ Active HCPCS Level II 2026
Open Q2057 in the app →

Look up Q2057 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.

Q2057 is the HCPCS Level II code for Afamitresgene autoleucel, including leukapheresis and dose preparation procedures, per therapeutic dose (2026). It belongs to Section Q — Temporary Codes. Under Medicare, its coverage status is: Carrier judgment. Part B pricing methodology: Drugs.

Classification & CMS Attributes

Medicare Coverage
Carrier judgment (code C)
Part B Pricing
Drugs (indicator 51)
Type of Service
Medical care
Effective Date
2026-01-01
2026 Maintenance
Payment change

References

Cite This Page

Reference Q2057 with the canonical source and edition:

Q2057 — Afamitresgene autoleucel, including leukapheresis and dose preparation procedures, per therapeutic dose. ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/Q2057

Canonical URL: https://icd10codingpro.com/hcpcs-codes/Q2057

Related Codes in Section Q

← Q2056 Ciltacabtagene car-pos t Q2058 → Obecbtge autol up to 400 mil
Q2053 Brexucabtagene car pos t Q2054 Lisocabtagene mara car pos t Q2055 Idecabtagene vicleucel car Q2056 Ciltacabtagene car-pos t Q2058 Obecbtge autol up to 400 mil Q3001 Brachytherapy radioelements Q3014 Telehealth facility fee Q3027 Inj beta interferon im 1 mcg Q3028 Inj beta interferon sq 1 mcg Q3031 Collagen skin test
Browse all HCPCS Level II sections →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2026-01-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial